An Open Two-way Cross-over Study to Evaluate the Effect of Multiple Doses of Flibanserin 100 mg Film-coated Tablets Given Once Daily on the Single Dose Pharmacokinetics of Digoxin 0.5 mg in Healthy Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2011
At a glance
- Drugs Digoxin; Flibanserin
- Indications Atrial fibrillation; Atrial flutter; Female sexual dysfunction; Heart failure
- Focus Pharmacokinetics
- 17 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
- 17 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.